Sign In

Heike Keilhack

SVP Biological Sciences at Ribon Therapeutics

Professional Background

Heike Keilhack is a highly accomplished scientist with an impressive background in biochemistry and biological sciences. Currently, she serves as the Senior Vice President of Biological Sciences at Ribon Therapeutics, a position that showcases her leadership and expertise in the burgeoning field of RNA-targeted therapies. With over two decades of experience in the pharmaceutical and biotech industries, Heike has made substantial contributions to drug development and research, particularly in oncology and rare diseases.

Prior to her current role at Ribon Therapeutics, Heike held the position of Vice President of Biological Sciences at the same organization. During her tenure, she was instrumental in steering Ribon’s research programs and enhancing the company's portfolio of innovative therapies. Her leadership at Ribon demonstrates her adeptness at bridging the gap between scientific research and practical, therapeutic applications that can significantly impact patient outcomes.

Before joining Ribon, Heike was a Senior Director at Epizyme, where she played a crucial role in developing novel therapeutics targeting epigenetic pathways. Her work at Epizyme was marked by strategic planning and scientific direction, further solidifying her reputation as a leader in biological sciences. Previously, she advanced through various roles at Epizyme, starting as a Director and contributing to the company's mission of developing impactful medicines.

Throughout her career, Heike has also made valuable contributions during her time as a Research Fellow at Merck, where she engaged in pioneering research efforts that laid the groundwork for innovative drug development initiatives. As a Principal Investigator at the Serono Research Institute, she led teams in exploring critical research questions, demonstrating her exceptional management skills and scientific acumen.

Heike's academic journey is equally remarkable, having completed her postdoctoral fellowship at the prestigious Harvard Medical School. Her rigorous training during this critical phase of her career provided her with the foundational skills and insights necessary to excel in the fast-paced world of drug discovery and development.

Education and Achievements

Heike Keilhack earned her diploma in Biochemistry from The Martin Luther University of Halle-Wittenberg, where she laid the groundwork for her expertise in biochemical research. Her educational background has been a significant factor in her successful career, enabling her to navigate complex scientific challenges and contribute to advancements in therapeutic science.

Her formal education and subsequent research experiences have equipped her with a deep understanding of the biochemical processes underlying health and disease. This knowledge has been fundamental in her work throughout her various esteemed positions in the biotech industry. Heike’s rich academic and professional journey reflects her dedication to scientific excellence and innovation.

Notable Achievements

  • Heike Keilhack is recognized as a thought leader in biological sciences, with numerous publications that have advanced the understanding of drug development processes and biochemical pathways in therapeutic applications.
  • As a Senior Vice President at Ribon Therapeutics, she has significantly influenced the strategic direction of the company, leading research and development efforts that are on the cutting edge of scientific discovery.
  • During her time at Epizyme, Heike contributed to the development of successful therapeutic candidates that addressed critical unmet medical needs in oncology, showcasing her critical role in addressing the challenges of cancer treatment.
  • At Merck and the Serono Research Institute, her research contributions helped elevate the scientific dialogue around drug discovery, indicating her capacity to foster innovation in highly competitive environments.

tags:[

Ribon Therapeutics

Biological Sciences

Biochemistry

Drug Development

Oncology

Pharmaceutical Industry

Biotech

Leadership

Research Fellow

Harvard Medical School

Epigenetics

Clinical Research

Related Questions

How did Heike Keilhack's education at The Martin Luther University of Halle-Wittenberg shape her career in biochemistry?
What are some of the key projects that Heike Keilhack has led at Ribon Therapeutics?
How has Heike Keilhack's experience at Epizyme influenced her current role in the biotech industry?
In what ways did Heike Keilhack's time at Harvard Medical School prepare her for leadership in biological sciences?
What innovations in drug development can be attributed to Heike Keilhack's expertise and leadership?
H
Add to my network

Location

Belmont, Massachusetts, United States